Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Theravance, Inc.”

369 pharma patents match "Theravance, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 369
Index total 30,257
Page 8 / 16

Quick answer

This filtered view shows 369 pharmaceutical patents matching "Theravance, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

369 results for “Theravance, Inc.” · 30,257 patents in full index Clear search

  1. US 7851467

    Carbamate compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted

  2. US 7851632

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted

  3. US 7846973

    Chemical process and new crystalline form

    Theravance, Inc. · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted

  4. US 7842704

    Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Theravance, Inc. · Granted Nov 30, 2010 · Expires Nov 25, 2030

    granted

  5. US 7838535

    Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Theravance, Inc. · Granted Nov 23, 2010 · Expires Nov 18, 2030

    granted

  6. US 7834185

    Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Nov 16, 2010 · Expires Nov 11, 2030

    granted

  7. US 7834041

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted Nov 16, 2010 · Expires Nov 11, 2030

    granted

  8. US 7829583

    Biphenyl derivatives

    Theravance, Inc. · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted

  9. US 7829728

    Diarymethyl and related compounds

    Theravance, Inc. · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted

  10. US 7816532

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted

  11. US 7803812

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Sep 28, 2010 · Expires Sep 23, 2030

    granted

  12. US 7790766

    Pharmaceutical compositions of short-acting sedative hypnotic agent

    Theravance, Inc. · Granted Sep 7, 2010 · Expires Sep 2, 2030

    granted

  13. US 7786136

    Indazole-carboxamide compounds

    Theravance, Inc. · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted

  14. US 7777077

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted Aug 17, 2010 · Expires Aug 12, 2030

    granted

  15. US 7772434

    Crystalline form of a β2 adrenergic receptor agonist

    Theravance, Inc. · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted

  16. US 7772239

    Benzoimidazolone-carboxamide compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted

  17. US 7772250

    Compounds

    Theravance, Inc. · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted

  18. US 7763637

    Quinolinone-carboxamide compounds as 5-HT4, receptor agonists

    Theravance, Inc. · Granted Jul 27, 2010 · Expires Jul 22, 2030

    granted

  19. US 7759363

    Benzimidazole-carboxamide compounds as 5-HT4, receptor agonists

    Theravance, Inc. · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted

  20. US 7732441

    Azabicycloalkane compounds

    Theravance, Inc. · Granted Jun 8, 2010 · Expires Jun 3, 2030

    granted

  21. US 7728144

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jun 1, 2010 · Expires May 27, 2030

    granted

  22. US 7728127

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Jun 1, 2010 · Expires May 27, 2030

    granted

  23. US 7728104

    Process for preparing glycopeptide phosphonate derivatives

    Theravance, Inc. · Granted Jun 1, 2010 · Expires May 27, 2030

    granted

  24. US 7728006

    Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Jun 1, 2010 · Expires May 27, 2030

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.